Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 15

1.

A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: impact on regeneration.

Gonçalves NP, Oliveira H, Pêgo AP, Saraiva MJ.

Nanomedicine (Lond). 2012 Aug;7(8):1167-80. doi: 10.2217/nnm.11.188. Epub 2012 Apr 4.

PMID:
22475646
2.
3.

Biological targeting and innovative therapeutic interventions with phage-displayed peptides and structured nucleic acids (aptamers).

Ahmadvand D, Rahbarizadeh F, Moghimi SM.

Curr Opin Biotechnol. 2011 Dec;22(6):832-8. doi: 10.1016/j.copbio.2011.02.012. Epub 2011 Mar 17. Review.

PMID:
21420292
4.

Development and testing of an innovative user-adjustable support surface for wheelchair seating discomfort.

Crane B, Hobson D, Stadelmeier S.

Assist Technol. 2010 Fall;22(3):152-62. doi: 10.1080/10400430903519936.

PMID:
20939424
5.

Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Roukos DH.

Ann Surg Oncol. 2010 Jan;17(1):14-7. doi: 10.1245/s10434-009-0766-0. Epub 2009 Oct 20. No abstract available.

6.

Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.

Zinzalla G, Thurston DE.

Future Med Chem. 2009 Apr;1(1):65-93. doi: 10.4155/fmc.09.12. Review.

8.

N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.

Babizhayev MA, Guiotto A, Kasus-Jacobi A.

J Drug Target. 2009 Jan;17(1):36-63. doi: 10.1080/10611860802438736 .

PMID:
19037813
9.

Development of Salmonella strains as cancer therapy agents and testing in tumor cell lines.

Eisenstark A, Kazmierczak RA, Dino A, Khreis R, Newman D, Schatten H.

Methods Mol Biol. 2007;394:323-54. doi: 10.1007/978-1-59745-512-1_16.

PMID:
18363243
10.

Innovative approaches for the treatment of depression: targeting the HPA axis.

Thomson F, Craighead M.

Neurochem Res. 2008 Apr;33(4):691-707. Epub 2007 Oct 25. Review.

PMID:
17960478
12.

Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.

Ferrari P, Micheletti R, Valentini G, Bianchi G.

Med Hypotheses. 2007;68(5):1120-5. Epub 2006 Nov 17.

PMID:
17113239
13.

Targeting evaluations of youth development-oriented community partnerships.

Surko M, Lawson HA, Gaffney S, Claiborne N.

J Public Health Manag Pract. 2006 Nov;Suppl:S95-107.

PMID:
17035910
14.
15.

Targeted use of siRNA in animal models of hepatic damage: an innovative therapy for acute liver failure.

Guicciardi ME, Gores GJ.

J Hepatol. 2003 Nov;39(5):883-5. No abstract available.

PMID:
14568278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk